Clik here to view.
Broad Institute, IBM Watson launch initiative to study cancer drug resistance
IBM Watson Health (NYSE:IBM) and the Broad Institute said today that they’ve launched a research initiative with the hopes of discovering the basis for cancer drug resistance. The 5 year, $50 million...
View ArticleClik here to view.
Misonix shares slightly up despite missing Q1 filing deadline
Misonix (NSDQ:MSON) today saw shares rise slightly despite saying it will miss the filing deadline for its quarterly report due to an ongoing investigation, according to an SEC filing posted today. The...
View ArticleClik here to view.
RIP serial medtech entrepreneur Spencer | Personnel Moves November 10, 2016
Serial medtech entrepreneur Dale Spencer died last week in Scottsdale, Ariz, according to the Medical Alley Association. Spencer helped found more than a dozen medical device companies, including...
View ArticleClik here to view.
Malaysian regulators issue new guidance on combination products
By Stewart Eisenhart, Emergo Group EMERGO SUMMARY OF KEY POINTS: Malaysian regulators have proposed a familiar approach for registration of combination products. How a combination product would be...
View ArticleClik here to view.
FDA approves Medtronic’s Claria MRI quad CRT-D
Medtronic (NYSE:MDT) said today that it won pre-market approval from the FDA for its Claria MRI quad cardiac resynchronization therapy defibrillator for magnetic resonance imaging scans at both 1.5 and...
View ArticleClik here to view.
Novo Nordisk’s Fiasp wins EU nod; Danish firm plans emerging markets push
Novo Nordisk (NYSE:NVO) said today that the European Union’s Committee for Medicinal Products for Human Use issued a positive opinion on its fast-acting insulin analogue, Fiasp. The Danish company...
View ArticleClik here to view.
LeMaitre Vascular pays $14m for Restore Flow Allografts
LeMaitre Vascular (NSDQ:LMAT) said last week that it agreed to put up $14 million for tissue preservation service provider Restore Flow Allografts. The deal calls for Burlington, Mass.-based LeMaitre...
View ArticleClik here to view.
Large joint procedure volumes rose 6% last year in US registry
The volume of large-joint replacement procedures in the U.S. rose more than 6% last year compared with 2014, according to the American Joint Replacement Registry. There were 161,040 hip and knee...
View ArticleClik here to view.
Sofregen buys Allergan’s Seri surgical scaffold
Sofregen Medical said today that it bought the Seri surgical scaffold from Allergan (NYSE:AGN) for an undisclosed amount. Polaris Partners and other investors provided financing for the acquisition,...
View ArticleClik here to view.
Final FDA rules clarify adverse event reporting for contract manufacturers
The FDA last week issued final guidance for medical device companies on the requirements for reporting adverse events that walked back much of the burden for contract manufacturers. The federal safety...
View ArticleClik here to view.
Are tiny ‘supermagnets’ the future of drug delivery?
Researchers from Quingdou University of Science and Technology in China developed a method to produce “supermagnets” that could one day be used as targeted drug delivery vehicles. The team’s work was...
View ArticleClik here to view.
Switzerland’s SFS Group to acquire contract manufacturer Tegra Medical
Swiss fastening system component manufacturer SFS Group said today it is acquiring contract manufacturer Tegra Medical for an undisclosed amount. Tegra Medical will continue to operate under the Tegra...
View ArticleClik here to view.
Fractyl eyes insulin resistance in fatty liver disease
Fractyl Laboratories presented data last week at the annual meeting of the American Assn. for the Study of Liver Diseases, touting its Revita duodenum mucosal resurfacing device in patients with...
View ArticleClik here to view.
OCUL’s Dextenza meets endpoints in pivotal study
Ocular Therapeutix (NSDQ:OCUL) said today that its post-surgical ocular pain reliever, Dextenza, met both primary endpoints in a pivotal trial for the treatment of post-surgical ocular inflammation...
View ArticleClik here to view.
Novartis mulls sale for underperforming Alcon eye division
Novartis (NYSE:NVS) is considering a possible divesture of its struggling Alcon eyecare business, according to chairman Joerg Reinhardt. Alcon was purchased from Swiss food maker Nestle for $52 billion...
View ArticleClik here to view.
Genetesis lands $1m seed round for CardioFlux heart imaging device
Genetesis said today that it raised a $1.2 million seed round for its CardioFlux heart imaging device. Cincinatti-based Genetesis said the round was led by CincyTech and Mark Cuban’s Radical...
View ArticleClik here to view.
Stryker signs on for 20-year hitch in Indo UK Institute of Health’s Medicity...
Stryker (NYSE:SYK) said today it inked a 20-year collaborative deal with the Indo UK Institute of Health’s Medicity Program as a preferred partner in the orthopedic hip, knee and trauma product and...
View ArticleClik here to view.
Philips launches world’s 1st detector-based spectral CT scanner in Canada
Royal Philips (NYSE:PHG) said today it launched its IQon spectral CT in Canada, touting it as the world’s 1st and only spectral CT scanner designed specifically for spectral imaging. The company’s...
View ArticleClik here to view.
St. Jude wins MRI nod for Proclaim Elite spinal cord stim
St. Jude Medical (NYSE:STJ) said today it won FDA approval for magnetic resonance imaging conditional labeling for its Proclaim Elite spinal cord stimulation system Patients using the company’s...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for November 14, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View Article
